News & Alerts
-
Sep- 2023 -5 September
UK Court Greenlights Legal Action Against Bayer Over Essure Contraceptive Device
Women in the United Kingdom who have reported harm from using Bayer’s Essure contraceptive device have received approval to pursue…
Read More » -
5 September
Amgen and FTC Reach Accord, Paving the Path for $28 Billion Horizon Deal
Amgen’s $28 billion acquisition of Horizon Pharma has overcome a significant obstacle with the resolution of its dispute with the…
Read More » -
5 September
List Of Top 20 Rare Diseases and Their Symptoms
A rare disease, colloquially referred to as an orphan disease, represents a medical conundrum that plagues a relatively minuscule fraction…
Read More » -
4 September
Healthcare Giants in the Spotlight: UnitedHealthcare vs. Prisma Health
The dispute between UnitedHealthcare and Prisma Health revolves around allegations of breach of contract and the disclosure of confidential information.…
Read More » -
2 September
Japanese Regulators Accept GSK’s Nucala Application For CRSwNP
GlaxoSmithKline (GSK) announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has accepted a supplementary new drug…
Read More » -
2 September
GSK Expands Vaccine Manufacturing With $273 Million Investment in Belgium
GlaxoSmithKline (GSK) is expanding its manufacturing operations in Belgium with a significant investment of over 250 million euros ($273 million).…
Read More » -
2 September
Counterfeit Pills Fueling Overdose Deaths in the U.S. – CDC Report
The United States is facing a concerning and escalating public health crisis as a growing number of overdose deaths are…
Read More » -
1 September
Otsuka Ventures into Psychedelic Medicines with Mindset Pharma Acquisition
Japanese pharmaceutical giant Otsuka is making a significant move into the emerging field of psychedelic medicines by acquiring Canada’s Mindset…
Read More » -
1 September
Sage Therapeutics Announces Major Restructuring Following Zurzuvae FDA Approval
Sage Therapeutics, in response to the FDA’s narrower-than-expected approval of its flagship antidepressant Zurzuvae, has announced significant changes to its…
Read More » -
1 September
Primate Antibody Treatment Prevents Organ Rejection After Transplant – Study
A recent study conducted in non-human primates has unveiled promising potential in using a manmade monoclonal antibody to address the…
Read More »